Safety, tolerability, pharmacokinetics, and pharmacodynamics of GLPG1690, a novel autotaxin inhibitor, to treat idiopathic pulmonary fibrosis (FLORA): a phase 2a randomised placebo-controlled trial

Toby M. Maher, Ellen M. van der Aar, Olivier Van de Steen, +7

The Lancet Respiratory Medicine

FibrosisNovel Autotaxin InhibitorAllergyMedicinePulmonary Fibrosis +5

Synthesis and antiprotozoal activity of some new synthetic substituted quinoxalines

Hui Xu, Julie Desrivot, Christian Bories, +4

Bioorganic & Medicinal Chemistry Letters

Medicinal ChemistryBioorganic ChemistryNatural SciencesAntiprotozoal ActivityOrganic Chemistry +3

Antileishmanial and trypanocidal activity of Brazilian Cerrado plants

Mariana Laundry de Mesquita, Julie Desrivot, Bories, +4

Memórias do Instituto Oswaldo Cruz

Medicinal ChemistryLeishmania DonovaniAntiparasitic AgentMedicineAntiprotozoal Activity +10

Antiparasitic activity of some New Caledonian medicinal plants

Julie Desrivot, Jean Waikedre, Pierre Cabalion, +4

Journal of Ethnopharmacology

Antiparasitic AgentHerbal MedicinePhytopharmacologyAntiparasitic ActivityPharmacology

High Content Analysis of Primary Macrophages Hosting Proliferating Leishmania Amastigotes: Application to Anti-leishmanial Drug Discovery

Nathalie Aulner, Anne Danckaert, Eline Rouault-Hardoin, +8

PLoS neglected tropical diseases

Synthesis and biological evaluation of a series of tangeretin-derived chalcones

Jérôme Quintin, Julie Desrivot, Sylviane Thoret, +3

Bioorganic & Medicinal Chemistry Letters

Tangeretin-derived ChalconesChemistryPharmacologySynthetic ChemistryBiomolecular Engineering +1

Clinical Confirmation that the Selective JAK1 Inhibitor Filgotinib (GLPG0634) has a Low Liability for Drug-drug Interactions

Florence Namour, Julie Desrivot, Annegret Van der Aa, +3

Drug Metabolism Letters

Safety, Pharmacokinetics, and Pharmacodynamics of the Autotaxin Inhibitor GLPG1690 in Healthy Subjects: Phase 1 Randomized Trials

Ellen van der Aar, Julie Desrivot, Sonia Dupont, +6

The Journal of Clinical Pharmacology

In vitro and in vivo antileishmanial efficacy of a new nitrilquinoline against Leishmania donovani

Héctor Nakayama, Julie Desrivot, Christian Bories, +5

Biomedicine & Pharmacotherapy

Medicinal ChemistryLeishmania DonovaniAntiparasitic AgentMedicineParasitic Protozoa +9

Antileishmanial 2-substituted quinolines: In vitro behaviour towards biological components

Julie Desrivot, Christine Herrenknecht, Gilles Ponchel, +7

Biomedicine & Pharmacotherapy

Medicinal ChemistryBioorganic ChemistryAntileishmanial 2-Substituted QuinolinesAntiparasitic AgentNatural Sciences +5